Single nucleotide polymorphisms of vitamin D binding protein, vitamin D receptor and retinoid X receptor alpha genes and response to hepatitis B vaccination in renal replacement therapy patients

Expert Review of Vaccines

Volumn 13, Issue 11, 2014, Pages 1395-1403

  Grzegorzewska, Alicja E ^a   Jodłowska, Elżbieta ^b   Mostowska, Adrianna ^c   Sowińska, Anna ^d   Jagodziński, Paweł P ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b PUMS   (Poland)

^c Student Nephrology Research Group   (Poland)

^d PUM   (Poland)

Author keywords

gene polymorphisms; HBV vaccination; hemodialysis; vitamin D; vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE; RECOMBINANT HEPATITIS B VACCINE; RETINOID X RECEPTOR ALPHA; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; HEPATITIS B VACCINE;

ADULT; AGED; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CLINICAL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEMODIALYSIS; HEPATITIS B; HOMOZYGOTE; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; RENAL REPLACEMENT THERAPY; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION; VERY ELDERLY; VITAMIN BLOOD LEVEL; ADOLESCENT; CHILD; GENETICS; IMMUNOLOGY; MIDDLE AGED; RENAL INSUFFICIENCY; TREATMENT FAILURE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GENE FREQUENCY; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RENAL INSUFFICIENCY; RENAL REPLACEMENT THERAPY; RETINOID X RECEPTOR ALPHA; TREATMENT FAILURE; VITAMIN D-BINDING PROTEIN; YOUNG ADULT;

EID: 84911473060     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.962521     Document Type: Article

References (32)

1. Bel'eed K, Wright M, Eadington D, et al. Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrad Med J 2002;78:538-40
2. Ghadiani MH, Besharati S, Mousavinasab N, Jalalzadeh M. Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patients. J Res Med Sci 2012;17:527-33
3. Al Saran K, Sabry A, Al Halawany Z, Ismail M. Factors affecting response to hepatitis B vaccine among hemodialysis patients in a large Saudi Hemodialysis Center. Saudi J Kidney Dis Transpl 2014;25:185-91
4. Brown CM, Donlon S, O'Kelly P, et al. A prospective study of hepatitis B vaccination-a comparison of responders versus nonresponders. Ren Fail 2011;33: 276-9
5. Shakhgil'dian IV, Khukhlovich PA, Savin EA, et al. [Risk of infection with hepatitis B and C viruses of medical workers, patients in the hemodialysis ward, and vaccine prophylaxis of hepatitis B infection in these populations]. Article in Russian Vopr Virusol 1994;39:226-9
6. Magnani G, Calzetti C, Campari M, et al. [Immune response to hepatitis B vaccine and duration of protection in a dialysis unit]. Article in Italian Acta Biomed Ateneo Parmense 1987;58:41-7
7. Fernández E, Betriu MA, Gómez R, Montoliu J. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 1996;11:1559-63
8. Zitt E, Sprenger-Mähr H, Knoll F, et al. Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine 2012;30:931-5
9. Van der Stede Y, Cox E, Van den broeck W, Goddeeris BM. Enhanced induction of the IgA response in pigs by calcitriol after intramuscular immunization. Vaccine 2001;19:1870-8
10. Ivanov AP, Dragunsky EM, Chumakov KM . 1,25-dihydroxyvitamin D3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice. J Infect Dis 2006;193:598-600
11. Santos BR, Mascarenhas LP, Satler F, et al. Vitamin D deficiency in girls from South Brazil: a cross-sectional study on prevalence and association with vitamin D receptor gene variants. BMC Pediatr 2012;12:62
12. Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010;19:2739-45
13. Hibler EA, Jurutka PW, Egan JB, et al. Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites. J Steroid Biochem Mol Biol 2010;121:438-41
14. Ovsyannikova IG, Dhiman N, Haralambieva IH, et al. Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet 2010;127:207-21
15. Ovsyannikova IG, Haralambieva IH, Vierkant RA, et al. Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine. Pharmacogenet Genomics 2012;22:20-31
16. Mast EE, Weinbaum CM, Fiore AE, et al. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006;55(RR-16): 1-33
17. Momplaisir F, Frank I, Meyer W III, et al. Vitamin D levels, natural H1N1 infection and response to H1N1 vaccine among HIV-infected individuals. J AIDS Clin Res 2012;3:152
18. Sundaram ME, Talbot HK, Zhu Y, et al. Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old. Vaccine 2013;31:2057-61
19. Kriesel JD, Spruance J. Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 1999;17:1883-8
20. Cooper C, Thorne A; Canadian Hiv Trials Network Ctn Influenza Vaccine Research Group. Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adults. HIV Clin Trials 2011;12:275-6
21. Chadha MK, Fakih M, Muindi J, et al. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate 2011;71: 368-72
22. Heine G, Drozdenko G, Lahl A, et al. Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr 2011;65:329-34
23. Zheng Y, Li XG, Wang QZ, et al. Enhancement of vitamin A combined vitamin D supplementation on immune response to Bacille Calmette-Guérin vaccine revaccinated in Chinese infants. Asian Pac J Trop Med 2014;7:130-5
24. Antonen JA, Hannula PM, Pyhälä R, et al. Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 2000;86:56-61
25. WHO. WHO Scientific Group on the Prevention and Management of Osteoporosis. Prevention and Management of Osteoporosis. World Health Organ Tech Rep Ser 2003;921:1-164
26. Mehrotra R, Kermah D, Budoff M, et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008;3: 1144-51
27. Valtuenã J, González-Gross M, Huybrechts I, et al. Factors associated with vitamin D deficiency in European adolescents: the HELENA study. J Nutr Sci Vitaminol (Tokyo) 2013;59:161-71
28. Uitterlinden AG, Fang Y, Van Meurs JB, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004;338: 143-56
29. Luo XY, Yang MH, Wu FX, et al. Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus 2012;21:53-9
30. Carling T, Rastad J, Akerström G, Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 1998;83:2255-9
31. Mocharla H, Butch AW, Pappas AA, et al. Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: lack of correspondence with common allelic variants. J Bone Miner Res 1997;12:726-33
32. Grzegorzewska AE, Wobszal PM, Sowińska A, et al. Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection. Mol Biol Rep 2013;40:6899-911